Characteristics | All N = 300 | Cases N = 100 | Control N = 200 | p-value |
---|---|---|---|---|
Median age at HIV diagnosis (years) | 28.35 | 28.35 | 28.25 | 0.978 |
Median time HIV negative to positive (years) | 0.68 | 0.66 | 0.69 | 0.828 |
Median time HIV diagnosis to 1st ART (years) | 5.41 | 5.78 | 4.82 | 0.078 |
Gender | 0.611 | |||
Male | 282 (94%) | 94 (94%) | 188 (94%) | |
Female | 18 (6%) | 6 (6%) | 12 (6%) | |
Race/ethnicity | 0.024 | |||
Caucasian | 134 (44.7%) | 47 (47%) | 87 (43.5%) | |
African–American | 123 (41%) | 36 (36%) | 87 (43.5%) | |
Hispanic/Puerto Rican/Mexican | 28 (9.3%) | 13 (13%) | 15 (7.5%) | |
Asian/Pacific Islander | 5 (1.7%) | 0 | 5 (2.5%) | |
Native American/Alaskan Native | 3 (3%) | 3 (3%) | 0 | |
Other | 7 (2.3%) | 1 (1%) | 6 (3%) | |
Median time HIV diagnosis to last study visit (years) | 13.18 | 14.28 | 13.0384 | 0.201 |
Median time from HIV diagnosis to 1st serum date (years) | 2.18 | 1.38 | 2.53 | 0.009 |
Median time from HIV diagnosis to 2nd serum date (years) | 6.89 | 6.98 | 6.81 | 0.975 |
Median CD4 at 1st serum date (cells/μL) | 530 | 534.5 | 523 | 0.940 |
Median VL at 1st serum date (log10 copies/mL) | 3.66 | 3.72 | 3.65 | 0.471 |
Median CD4 at 2nd serum date (cells/μL) | 501 | 436 | 527 | 0.007 |
Median VL at 2nd serum date (log10 copies/mL) | 2.80 | 3.52 | 2.60 | 0.007 |
On ART at 1st serum date | 0.075 | |||
No | 201 (67%) | 73 (73%) | 128 (64%) | |
Yes | 99 (33%) | 27 (27%) | 72 (36%) | |
On ART at 2nd serum date | 0.025 | |||
No | 119 (39.7%) | 48 (48%) | 71 (35.5%) | |
Yes | 181 (60.3%) | 52 (52%) | 129 (64.5%) |